Australia Rejects US Pharma Tariff, Vows to Protect Affordable Healthcare
The Australian government is urgently investigating new US tariffs, particularly a potential 200% tax on pharmaceutical imports, which could impact its $2.2 billion pharmaceutical exports to the US. Treasurer Jim Chalmers expressed serious concern over the tariffs, emphasizing that the nation will not compromise its Pharmaceutical Benefits Scheme (PBS) to avoid them, despite pressure from US pharmaceutical lobbies. While the Productivity Commission suggests Australia could benefit from the tariffs by not retaliating, the government remains firm in its stance to protect the PBS, which provides cheaper medicines to its citizens.
John Q. Hosedrinker